Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

February 6, 2024

https://www.prnewswire.com/news-releases/precigen-to-participate-in-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302053717.html

GERMANTOWN, Md., Feb. 6, 2024 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference taking place virtually from February 13 to February 14, 2024. Precigen’s company presentation will take place on Tuesday, February 13 from 3:20 PM to 3:50 PM EST.

Read more at prnewswire.com

Related news for (PGEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.